Applications of DL-Alanyl-DL-Alanine in Industrial Manufacturing

As a direct manufacturer of DL-Alanyl-DL-Alanine, we supply this dipeptide to industrial clients who require consistently high quality for process-critical applications. Below are key sectors where major manufacturers integrate our material to achieve strict performance, regulatory, and product outcome objectives in their finished goods.

1. Peptide Synthesis for Research Reagents and APIs

Advanced laboratories and pharmaceutical facilities use DL-Alanyl-DL-Alanine as a protected dipeptide building block in custom peptide chain assembly. Precision peptide synthesis for research tools and regulated active pharmaceutical ingredients relies on transparent raw material traceability and consistency across scales. Our batches support high-throughput solid-phase and solution-phase synthesis workflows, meeting regulatory documentation needs for submission and lot tracking.

Industry compliance standards

• ICH Q7 GMP for Active Pharmaceutical Ingredient Manufacture
• Ph. Eur. (European Pharmacopoeia) for peptide standards
• USP General Chapter <797> for compounding quality
• CFR Title 21 Part 210/211 (USA FDA)

Typical usage ratio

• 5%–15% (w/w) of total monomer input; concentration varies by peptide length, coupling efficiency, and process route

Downstream process integration

• Direct raw material input for stepwise peptide elongation via Fmoc- or Boc-protected protocols
• Incorporation during resin loading or solution-phase chain assembly
• QC reference standard in chromatographic purity checks

Final product types

• Research-grade synthetic peptides
• API candidate libraries
• Peptide-based reference substances
• Small-peptide pharmaceutical intermediates

2. Amino Acid Solution Additive for Parenteral Nutrition

Our DL-Alanyl-DL-Alanine is supplied to parenteral nutrition compounding plants as a specialized additive to balance amino acid profiles in intravenous feeding formulations. Medical nutrition providers opt for controlled lots with authenticated purity and endotoxin status, as even minor impurities may impact product safety for vulnerable patient populations. Traceable raw material documentation and batch-specific testing reports address the procurement and regulatory requirements of contract manufacturers and pharmaceutical hospital supply chains.

Industry compliance standards

• USP <823> for amino acid sterilization requirements
• CFR Title 21 Part 121 (FDA Sterility Regulations)
• ISO 13408 for aseptic processing
• Pharmacopoeia monographs (USP, JP, EP) on amino acid injectables

Typical usage ratio

• 0.1%–0.5% of total amino acid solution content by weight; precise dosage calculated per prescription need and patient tolerance

Downstream process integration

• Weighing and dissolution into bulk amino acid solution tank prior to sterile filtration and aseptic filling
• Integrated with micron and endotoxin testing programs before packaging

Final product types

• IV amino acid infusions for parenteral nutrition
• Hospital-use total parenteral nutrition (TPN) bags
• Special clinical formulations for pediatric and renal patients

3. Microbial Fermentation and Culture Media Formulation

Industrial producers of biopharmaceuticals and specialty enzymes employ our material within complex microbial culture media to support growth and metabolic stability of bacterial, yeast, and mammalian cell lines. By providing a defined, bioavailable dipeptide, manufacturers increase yield consistency while meeting quality documentation for regulated fermentation output, especially in processes demanding strict batch reproducibility and minimal extraneous nitrogen source contamination.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems
• Pharmaceutical cGMP (21 CFR Parts 210/211)
• Food Chemicals Codex for enzymes/food-derived products
• ICH Q9/Q10 for quality risk management and operational excellence

Typical usage ratio

• 0.01%–0.2% (w/v) in total fermentation volume; exact level set per microbial strain amino acid preference, nitrogen source targets, and growth curve objectives

Downstream process integration

• Pre-autoclave media blending with other defined amino acids and precursors
• Post-sterilization addition for heat-labile strain requirements

Final product types

• Recombinant protein pharmaceuticals
• Industrial/food-grade enzyme preparations
• Cultured bacterial seed stocks

4. Nutritional Supplement Tablets and Functional Food Premixes

Manufacturers of direct-to-consumer dietary supplements and formulated food premixes use this dipeptide to customize amino acid composition for muscle support products, active lifestyle nutrition, and clinical diet formulations. Our food-grade lots undergo hazard analysis and process control documentation for full traceability in commercial blending and tableting operations, where consistency, flow characteristics, and homogeneity are critical for downstream product uniformity and consumer safety.

Industry compliance standards

• FSSC 22000 (Food Safety System Certification)
• FDA 21 CFR 111 (Dietary Supplement GMPs)
• EFSA food additive notifications
• GB 14880-2012 (China National Standard for food additives)

Typical usage ratio

• 0.1%–1.0% by mass in finished supplement blend; level selected based on synergistic amino acid matrix design and regulatory upper limits for protein fortification

Downstream process integration

• Dry blending with vitamins, minerals, and base amino acids prior to tableting or encapsulation
• Premix for ready-to-drink or instant food powder products

Final product types

• Sports nutrition tablets and capsules
• Fortified food beverage premixes
• Medical food supplements

5. Peptide Standard for Analytical Reference Materials

Analytical laboratories and quality control divisions procure our high-purity material for use as a calibration reference in chromatographic quantification of peptide-derived products. Traceable, lot-specific documentation and stability data support method validation, equipment calibration, and regulatory filing for pharmaceutical and biotech analytical programs. Batches undergo specialized QC tailored for analytical-grade reference applications, meeting strict impurity, homogeneity, and stability criteria outlined by global testing standards.

Industry compliance standards

• ISO/IEC 17025 (Testing and Calibration Laboratories)
• USP <621> Chromatography System Suitability
• ICH Q2 (R1) Analytical Procedure Validation
• AOAC International Analytical Methods

Typical usage ratio

• Used as 0.01 mg/mL–1.0 mg/mL calibration solution for HPLC/UPLC or MS quantitation; reference concentration set by analytical detection limits and accuracy requirements

Downstream process integration

• Preparation of stock and working calibration standards for chromatographic analysis
• Inclusion in inter-laboratory proficiency assessments

Final product types

• HPLC/UPLC system calibration solutions
• Chemical reference standards supplied in analytical kits
• Validated QC protocols for drug and research manufacturers